MRIPositive Diagnosis of Vestibular Neuritis Using Fluid Attenuated Inversion Recuperation (FLAIR) Sequence on a 1.5 Tesla

Vestibular Neuritis Clinical Trial

Official title:

Positive Diagnosis of Vestibular Neuritis Using Fluid Attenuated Inversion Recuperation (FLAIR) Sequence, One Hour After Intravenous Gadolinium Injection, on a 1.5 Tesla

Clinical Trial Details — Status: Completed

Administrative data

• NCT number: NCT03452410
• Other study ID #: 6786
• Status: Completed
• Start date: February 23, 2018
• Est. completion date: February 23, 2019

Study information

• Verified date: February 2018
• Source: University Hospital, Strasbourg, France
• Contact: n/a
• Is FDA regulated: No
• Study type: Observational

Clinical Trial Summary

Our objective is to allow positive MRI diagnosis of vestibular neuritis by highlighting contrast enhancement of the vestibular nerve on the pathological side of the FLAIR sequence acquired 1h after intravenous gadolinium injection in patients with typical vestibular neuritis. At present, the diagnosis is based on a combination clinical examination / video-head impulse test, and no imaging examination allows the diagnosis to be positive.

Recruitment information / eligibility

• Status: Completed
• Enrollment: 35
• Est. completion date: February 23, 2019
• Est. primary completion date: February 23, 2019
• Gender: All
• Age group: 18 Years to 80 Years

Eligibility

Inclusion Criteria:

• Age 18-80 years

• Presence of a typical unilateral vestibular neuritis during the ENT examination with videonystagmography

• Subject having his agreement for the use of his medical data for research purposes.

Exclusion Criteria:

• Special clinical forms of the disease: doubtful or atypical forms, especially the presence of deafness

• Treatments and related interfering diseases, antecedents: antecedents of neuritis for controls, presence of vertigo, bilateral involvement

• Impossibility to give the subject information enlightened (subject in emergency situation, difficulties of understanding the subject, ...)

• Subject under the protection of justice

• Subject under guardianship or curatorship

Related Conditions & MeSH terms

• Neuritis
• Vestibular Neuritis
• Vestibular Neuronitis

Locations

Country	Name	City	State
France	Service Imagerie 1	Strasbourg

Sponsors (1)

Lead Sponsor	Collaborator
University Hospital, Strasbourg, France

Country where clinical trial is conducted

France, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	Diagnosis of vestibular neuritis		one hour after intravenous gadolinium injection